ArticlePloS one2025

Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells.

Melchiorre Cervello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.